Now loading.
Please wait.

Menu

director.niv@icmr.gov.in

Dr. Pragya D. Yadav

HomeDr. Pragya D. Yadav
HomeDr. Pragya D. Yadav
single image

Dr. Pragya D. Yadav, (FIVS, MNAMS, MNASc), Scientist-F and Group Leader

Division: Maximum Containment Facility [BSL-4 Facility]

Educational qualifications: M.Sc (Biochemistry), PhD (Biotechnology)

Date of joining ICMR-NIV: 08.05.2004

  • Contact: 020-26006999, 020-26006959
  • Email: yadav.pragya@gov.in , hellopragya22@gmail.com
  • Office: Indian Council of Medical Research-National Institute of Virology Pune Maharashtra - 411001

 

Research Interests:

Virology (Nipah, SARS-CoV-2, Crimean Congo haemorrhagic fever virus, Zika, Ebola, Kyasanur Forest Disease, Bunyavirus, Dengue, Chikungunya, high risk group of pathogens, Respiratory diseases), Molecular biology, Public Health, Research & Development, and Biocontainment science, Molecular & Serological assay development and translation, new pathogen discovery, animal pathogenesis and pre-clinical research for high-risk viral pathogens, Biorisk mitigation and vaccine research.

 

Awards/Honours:

  • Featured in the E-Samvad Patrika of ICMR
  • Dr. K. M. Bhansali Oration award
  • Featured in the E-Samvad Patrika of ICMR
  • Certificate of appreciation
  • COVID worrier
  • Most Informative’ stall at the Mega Science Expo and was appreciated the contributions done by all the ICMR institutes in the field of public health-related issues all over the country.
  • IVS Fellow Award
  • Awarded Medal and Certificate
  • Achievers of the year 2016 Award
  • Dr. T Ramchandra Rao Award (Medical Entomology)
  • Young Scientist Awards [Molecular Biology]
  • Zoonosis Control Training Program Fellow
  • JICA fellows (Group training Course in Zoonosis Control)
  • Travel award to present paper in Asian Pacific Biosafety Association conference in Manila
  • Travel Award in ASV Conference.
  • International Emerging Infectious Disease laboratory training fellowship program
  • ICMR-JRF in Biomedical Sciences
  • ICAR NET

 

ORCID ID:0000-0002-0861-7166

Researcher ID: AAR-2431-2021

Google Scholar Profile Link

 

List of Publications
  • 1. Barde P.V., Rane S.R., Singh D.K., Yadav PD,Dighe V, Gokhale M.D. and Mourya D.T. Concomitant effect of Bacillus thuringiensis H-14 toxin and atropine sulphate on the gut epithelial cells of female Aedes aegypti mosquitoes. Entomon. 2003 28(2):161-163.
    2. Moury DT, Singh DK, Yadav P, Gokhale MD, Barde PV, Narayan NB, Thakare JP, Mishra AC, Shouche YS. Role of gregarine parasite Ascogregarina culicis (Apicomplexa: Lecudinidae) in the maintenance of Chikungunya virus in vector mosquito. J Eukaryot Microbiol. 2003 Sep-Oct; 50(5):379-82. DOI: 10.1111/j.1550-7408.2003.tb00153.x. PMID: 14563178.
    3. Mourya DT, Rohankhedkar MS, Yadav P, Dighe V, Deobagkar DN. Enhanced esterase activity in salivary gland and midgut of Aedes aegypti mosquito infected with dengue-2 virus. Indian J Exp Biol. 2003 Jan; 41(1):91-3. PMID: 15267144.
    4. *Yadav P, Gokhale MD, Barde PV, Singh DK, Mishra AC, Mourya DT. Experimental transmission of Chikungunya virus by Anopheles stephensi mosquitoes. Acta Virol. 2003; 47(1):45-7. PMID: 12828344. 5. *Yadav PD, Shouche YS, Munot HP, Mishra AC, Mourya DT. Genotyping of Chikungunya virus isolates from India during 1963-2000 by reverse transcription-polymerase chain reaction. Acta Virol. 2003; 47(2):125-7. PMID: 14524480.
    6. Mourya DT, Yadav P, Mishra AC. Effect of temperature stress on immature stages and susceptibility of Aedes aegypti mosquitoes to chikungunya virus. Am J Trop Med Hyg. 2004 Apr; 70(4):346-50. DOI: 10.4269/ajtmh.2004.70.346.PMID: 15100445.
    7. *Yadav P, Barde PV, Jadi R, Gokhale MD, Basu A, Joshi MV, Mehla R, Kumar SR, Athavale SS, Mourya DT. Isolation of bovine viral diarrhea virus 1, a pestivirus from autopsied lamb specimen from Tamil Nadu, India. Acta Virol. 2004; 48(4):223-7. PMID: 15745045.
    8. Yadav Pragya (Thesis). Study on the identification and expression of certain pathogen responsive genes in vector mosquito Aedes aegypti. Savitribai Phule Pune University, 2003 http://hdl.handle.net/10603/143157
    9. *Yadav PD, Barde PV, Gokhale MD, Vipat V, Mishra AC, Pal JK, Mourya DT. Effect of temperature and insecticide stresses on Aedes aegypti larvae and their influence on the susceptibility of mosquitoes to dengue-2 virus. Southeast Asian J Trop Med Public Health. 2005 Sep; 36(5):1139-44. PMID: 16438138.
    10. Mourya DT, Yadav PD and Mishra AC. The current status of Chikungunya virus in India: A review. Golden jubilee publication of NIV compendium. 2004, 265-267 (Book chapter)
    11. *Yadav PD, Vincent MJ, Nichol ST. Thottapalayam virus is genetically distant to the rodent-borne hantaviruses, consistent with its isolation from the Asian house shrew (Suncus murinus). Virol J. 2007 Aug 21; 4:80. DOI:10.1186/1743-422X-4-80. PMID: 17711577; PMCID: PMC1997112.
    12. Mourya DT, Yadav PD. Insect immune responses and vector competence of mosquitoes. Integrated Pest Management and Biocontrol, Pointer Publishers, Jaipur 2006, 275-286. (Book chapter)
    13. Mourya DT, Yadav P. Vector biology of dengue & chikungunya viruses. Indian J Med Res. 2006 Nov; 124(5):475-80. PMID: 17213513. (Review)
    14. Yadav PD, Mishra AC, Mourya DT. Molecular characterization of Umbre virus (Bunyaviridae). Virol J. 2008 Oct 8; 5:115. DOI:10.1186/1743-422X-5-115.PMID:18842123; PMCID: PMC2586634.
    15. Mehla R, Kumar SR, Yadav P, Barde PV, Yergolkar PN, Erickson BR, Carroll SA, Mishra AC, Nichol ST, Mourya DT. Recent ancestry of Kyasanur Forest disease virus. Emerg Infect Dis. 2009 Sep; 15(9):1431-7.DOI: 10.3201/eid1509.080759. PMID: 19788811; PMCID: PMC2819879.
    16. Sivaram A, Barde PV, Kumar SR, Yadav P, Gokhale MD, Basu A, Mourya DT. Isolation and characterization of densonucleosis virus from Aedes aegypti mosquitoes and its distribution in India. Intervirology. 2009; 52(1):1-7. DOI: 10.1159/000210044. Epub 2009 Mar 31. PMID: 19332994.
    17. Kumar SR, Patil JA, Cecilia D, Cherian SS, Barde PV, Walimbe AM, Yadav PD, et al. Evolution, dispersal and replacement of American genotype dengue type 2 viruses in India (1956-2005): selection pressure and molecular clock analyses. J Gen Virol. 2010 Mar; 91(Pt 3):707-20. DOI: 10.1099/vir.0.017954-0. Epub 2009 Nov 18. PMID: 19923266.
    18. Gurav YK, Raut CG, Yadav PD, Tandale BV, Sivaram A, Pore MD, Basu A, Mourya DT, Mishra AC. Buffalopox outbreak in humans and animals in Western Maharashtra, India. Prev Vet Med. 2011 Jul 1; 100(3-4):242-7. DOI: 10.1016/j.prevetmed.2011.03.008. Epub 2011 Apr 20. PMID: 21511350.
    19. *Yadav PD, Vincent MJ, Khristova M, Kale C, Nichol ST, Mishra AC, Mourya DT. Genomic analysis reveals Nairobi sheep disease virus to be highly diverse and present in both Africa, and in India in the form of the Ganjam virus variant. Infect Genet Evol. 2011 Jul; 11(5):1111-20. DOI: 10.1016/j.meegid.2011.04.001. Epub 2011 Apr 12. PMID: 21511058.
    20. Raut CG, Yadav PD, Towner JS, Amman BR, Erickson BR, Cannon DL, Sivaram A, Basu A, Nichol ST, Mishra AC, Mourya DT. Isolation of a novel adenovirus from Rousettus leschenaultia bats from India. Intervirology. 2012; 55(6):488-90. DOI: 10.1159/000337026. Epub 2012 May 3. PMID: 22572722.
    21. *Yadav PD, Raut CG, Shete AM, Mishra AC, Towner JS, Nichol ST, Mourya DT. Detection of Nipah virus RNA in fruit bat (Pteropus giganteus) from India. Am J Trop Med Hyg. 2012 Sep; 87(3):576-8. DOI: 10.4269/ajtmh.2012.11-0416. Epub 2012 Jul 16. PMID: 22802440; PMCID: PMC3435367.
    22. Mourya DT, Yadav PD, Mehla R, Barde PV, Yergolkar PN, Kumar SR, Thakare JP, Mishra AC. Diagnosis of Kyasanur forest disease by nested RT-PCR, real-time RT-PCR and IgM capture ELISA. J Virol Methods. 2012 Dec; 186(1-2):49-54. DOI: 10.1016/j.jviromet.2012.07.019. Epub 2012 Jul 31. PMID: 22874757.
    23. Mourya DT, Yadav PD, Shete AM, Gurav YK, Raut CG, Jadi RS, Pawar SD, Nichol ST, Mishra AC. Detection, isolation and confirmation of Crimean-Congo hemorrhagic fever virus in human, ticks and animals in Ahmadabad, India, 2010-2011. PLoS Negl Trop Dis. 2012; 6(5):e1653. DOI: 10.1371/journal.pntd.0001653. Epub 2012 May 15. PMID: 22616022; PMCID: PMC3352827.
    24. Mourya DT, Yadav PD and Raut CG. High Containment Laboratory and Virus Repository group. National Institute of Virology, Golden to Diamond Jubilee: The glorious decade. Edited by V Arankalle and D Cecilia. 2012: pp. 319-358. (Book chapter)
    25. *Yadav PD, Raut CG, Patil DY. et al. Crimean-Congo Hemorrhagic Fever: Current Scenario in India. Proc. Natl. Acad. Sci., India, Sect. B Biol. Sci. 84, 9–18 (2014). DOI: https://doi.org/10.1007/s40011-013-0197-3. (Review)
    26. *Yadav PD, Sudeep AB, Mishra AC, Mourya DT. Molecular characterization of Chittoor (Batai) virus isolates from India. Indian J Med Res. 2012 Nov; 136(5):792-8. PMID: 23287126; PMCID: PMC3573600.
    27. *Yadav PD, Raut CG, Mourya DT. Re-occurrence of Crimean-Congo haemorrhagic fever in Ahmedabad, Gujarat, India (2012): a fatal case report. Indian J Med Res. 2013 Dec; 138(6):1027-8. PMID: 24521654; PMCID: PMC3978959.
    28. Mourya DT, Yadav PD, Sandhya VK, Reddy S. Spread of Kyasanur Forest disease, Bandipur Tiger Reserve, India, 2012-2013. Emerg Infect Dis. 2013; 19(9):1540-1.
    29. Mourya DT, Lakra RJ, Yadav PD, Tyagi P, Raut CG, Shete AM, Singh DK. Establishment of cell line from embryonic tissue of Pipistrellus ceylonicus bat species from India & its susceptibility to different viruses. Indian J Med Res. 2013; 138(2):224-31. PMID: 24056599; PMCID: PMC3788208.
    30. *Yadav PD, Cherian SS, Zawar D, Kokate P, Gunjikar R, Jadhav S, Mishra AC, Mourya DT. Genetic characterization and molecular clock analyses of the Crimean-Congo hemorrhagic fever virus from human and ticks in India, 2010-2011. Infect Genet Evol. 2013 Mar; 14:223-31. DOI: 10.1016/j.meegid.2012.10.005. Epub 2012 Nov 27. PMID: 23195573.
    31. Kasabi GS, Murhekar MV, Yadav PD,Raghunandan R, Kiran SK, Sandhya VK, Channabasappa GH, Mishra AC, Mourya DT, Mehendale SM. Kyasanur Forest disease, India, 2011-2012. Emerg Infect Dis. 2013 Feb; 19(2):278-81. DOI: 10.3201/eid1902.120544. PMID: 23343570; PMCID: PMC3559039.
    32. *Yadav PD,Gurav YK, Mistry M, Shete AM, Sarkale P, Deoshatwar AR, Unadkat VB, Kokate P, Patil DY, Raval DK, Mourya DT. Emergence of Crimean-Congo hemorrhagic fever in Amreli District of Gujarat State, India, June to July 2013. Int J Infect Dis. 2014 Jan; 18:97-100. DOI: 10.1016/j.ijid.2013.09.019. Epub 2013 Nov 7. PMID: 24211848.
    33. Mourya DT, Yadav PD, and Patil DY. Highly infectious tick-borne viral diseases: Kyasanur forest disease and Crimean-Congo haemorrhagic fever in India. WHO Southeast Asia J Public Health. 2014 Jan-Mar; 3(1):8-21. DOI: 10.4103/2224-3151.206890. PMID: 28607249. (Review)
    34. Mourya DT, Yadav PD,Basu A, Shete A, Patil DY, Zawar D, Majumdar TD, Kokate P, Sarkale P, Raut CG, Jadhav SM. Malsoor virus, a novel bat phlebovirus, is closely related to severe fever with thrombocytopenia syndrome virus and heartland virus. J Virol. 2014 Mar; 88(6):3605-9. DOI: 10.1128/JVI.02617-13. Epub 2014 Jan 3. PMID: 24390329; PMCID: PMC3957954.
    35. Mourya DT, Yadav PD, Majumdar TD, Chauhan DS, Katoch VM. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting. Indian J Med Res. 2014 Aug; 140(2):171-183. PMID: 25297350; PMCID: PMC4216491. (Review)
    36. Mourya DT, Yadav PD,Shete A, Majumdar TD, Kanani A, Kapadia D, Chandra V, Kachhiapatel AJ, Joshi PT, Upadhyay KJ, Dave P, Raval D. Serosurvey of Crimean-Congo hemorrhagic fever virus in domestic animals, Gujarat, India, 2013. Vector Borne Zoonotic Dis. 2014 Sep; 14(9):690-2. DOI: 10.1089/vbz.2014.1586. PMID: 25229708.
    37. *Yadav PD,Shete AM, Patil DY, Sandhya VK, Prakash KS, Surgihalli R, Mourya DT. Outbreak of Kyasanur Forest disease in Thirthahalli, Karnataka, India, 2014. Int J Infect Dis. 2014 Sep; 26:132-4. DOI: 10.1016/j.ijid.2014.05.013. Epub 2014 Jul 22. PMID: 25063021.
    38. Sudeep A.B., Hundekar S.L., Yadav PD and Mourya, D.T. Detection of chikungunya virus IgM antibodies in human serum samples using virus infected Aedes aegypti mosquito head squashes. Int J Scientific Res. 2014 Nov; 3(11)372-73. DOI: 10.36106/ijsr.
    39. Mourya DT, Yadav PD, Mullick J, Patil DR. Biosafety Manual for laboratory Institutional Document 2014. (Book chapter)
    40. Mourya DT, Yadav PD, Shete AM, Sathe PS, Sarkale PC, Pattnaik B, Sharma G, Upadhyay KJ, Gosavi S, Patil DY, Chaubal GY, Majumdar TD, Katoch VM. Cross-sectional Serosurvey of Crimean-Congo Hemorrhagic Fever Virus IgG in Livestock, India, 2013-2014. Emerg Infect Dis. 2015 Oct; 21(10):1837-9. DOI: 10.3201/eid2110.141961. PMID: 26402332; PMCID: PMC4593432.
    41. Basu A, Yadav P, Prasad S, Tadkalkar N, Mourya DT (2015) Ultrastructure and Morphogenesis of Malsoor Virus: A Novel Phlebovirus Genetically Related to the Severe Fever with Thrombocytopenia Virus. J Hum Virol Retrovirol 2(1): 00026. DOI: 10.15406/jhvrv.2015.02.00026
    42. Makwana D, Yadav PD,Kelaiya A, Mourya DT. First confirmed case of Crimean-Congo haemorrhagic fever from Sirohi district in Rajasthan State, India. Indian J Med Res. 2015 Oct; 142(4):489-91. DOI: 10.4103/0971-5916.169221. PMID: 26609042; PMCID: PMC4683835.
    43. Badole SL, Yadav PD, Patil DR, Mourya DT. Animal models for some important RNA viruses of public health concern in SEARO countries: viral hemorrhagic fever. J Vector Borne Dis. 2015 Mar; 52(1):1-10. PMID: 25815861. (Review)
    44. Murhekar MV, Kasabi GS, Mehendale SM, Mourya DT, Yadav PD, Tandale BV. On the transmission pattern of Kyasanur Forest disease (KFD) in India. Infect Dis Poverty. 2015 Aug 19; 4:37. DOI: 10.1186/s40249-015-0066-9. PMID: 26286631; PMCID: PMC4545326.
    45. Tandale BV, Balakrishnan A, Yadav PD, Marja N, Mourya DT. New focus of Kyasanur Forest disease virus activity in a tribal area in Kerala, India, 2014. Infect Dis Poverty. 2015 Mar 5; 4:12. DOI: 10.1186/s40249-015-0044-2. PMID: 25750730; PMCID: PMC4351674.
    46. *Mourya, D.T., Yadav PD. Recent Scenario of Emergence of Kyasanur Forest Disease in India and Public Health Importance. Curr Trop Med Rep 2016; 3, 7–13. DOI: https://doi.org/10.1007/s40475-016-0067-1. (Review)
    47. Srinivas V, Yadav P, Mittal V, Chaubal G, Chhabra M, Mattoo S, Rai A, *Mourya DT. Follow-up of Ebola Patient, 2014-2015. Emerg Infect Dis. 2016 Apr; 22(4):748-50. DOI: 10.3201/eid2204.151405. PMID: 26981772; PMCID: PMC4806952.
    48. *Mourya DT, Shil P, Sapkal GN, Yadav PD. Zika virus: Indian perspectives. Indian J Med Res. 2016 May; 143(5):553-64. DOI: 10.4103/0971-5916.187103. PMID: 27487998; PMCID: PMC4989828. (Review)
    49. Awate P, Yadav P, Patil D, Shete A, Kumar V, Kore P, Dolare J, Deshpande M, Bagde S, Sapkal G, Gurav Y, *Mourya DT. Outbreak of Kyasanur Forest disease (monkey fever) in Sindhudurg, Maharashtra State, India, 2016. J Infect. 2016 Jun; 72(6):759-761. DOI: 10.1016/j.jinf.2016.03.006. Epub 2016 Mar 18. PMID: 26997635.
    50. Basu A, Yadav P, Prasad S, Badole S, Patil D, Kohlapure RM, *Mourya DT. An Early Passage Human Isolate of Kyasanur Forest Disease Virus Shows Acute Neuropathology in Experimentally Infected CD-1 Mice. Vector Borne Zoonotic Dis. 2016 Jul; 16(7):496-8. DOI: 10.1089/vbz.2015.1917. Epub 2016 May 12. PMID: 27171207.
    51. *Mourya DT, Shahani HC, Yadav PD, Barde PV. Use of hydrogen peroxide vapour & plasma irradiation in combination for quick decontamination of closed chambers. Indian J Med Res. 2016 Aug; 144(2):245-249.DOI: 10.4103/0971-5916.195039. PMID: 27934804; PMCID: PMC5206876.
    52. *Mourya DT, Sapkal GN, Yadav PD. Difference in vector ticks dropping rhythm governs the epidemiology of Crimean-Congo haemorrhagic fever &Kyasanur forest disease in India. Indian J Med Res. 2016 Oct; 144(4):633-635. DOI: 10.4103/0971-5916.200892. PMID: 28256476; PMCID: PMC5345314.
    53. *Yadav PD, Patil DY, Shete AM, Kokate P, Goyal P, Jadhav S, Sinha S, Zawar D, Sharma SK, Kapil A, Sharma DK, Upadhyay KJ, Mourya DT. Nosocomial infection of CCHF among health care workers in Rajasthan, India. BMC Infect Dis. 2016 Nov 3; 16(1):624. DOI: 10.1186/s12879-016-1971-7. PMID: 27809807; PMCID: PMC5094004.
    54. *Yadav P,Sarkale P, Patil D, Shete A, Kokate P, Kumar V, Jain R, Jadhav S, Basu A, Pawar S, Sudeep A, Gokhale M, Lakra R, Mourya D. Isolation of Tioman virus from Pteropus giganteus bat in North-East region of India. Infect Genet Evol. 2016 Nov; 45:224-229. DOI: 10.1016/j.meegid.2016.09.010. Epub 2016 Sep 9. PMID: 27619056; PMCID: PMC7106170.
    55. *Yadav P,Shete A, Bondre V, Patil D, Kokate P, Chaudhari S, Srivastava S, Jadhav S, Mourya D. Isolation and characterization of Oya virus a member of Simbu serogroup, family Bunyaviridae, isolated from Karnataka, India. Infect Genet Evol. 2016 Oct; 44:122-126. DOI: 10.1016/j.meegid.2016.06.049. Epub 2016 Jun 29. PMID: 27374486.
    56. Mourya DT, Yadav PD. Nairobi Sheep Disease virus. Dongyou Liu (Ed.) Molecular detection of animal viral pathogens, CRC Press, May 12, 2016, Chapter 60. ISBN: 9781498700368. eBook ISBN: 9781498700375 [Book Chapter]
    57. Mourya DT, Sakpal G, Sudeep AB, Mullick J, Shete A, Yadav PD, Patil D. Virology Technical Manual. Indian J Med Res. 2016, pp1-300. [Book]
    58. Sapkal GN, Yadav PD,Vegad MM, Viswanathan R, Gupta N, *Mourya DT. First laboratory confirmation on the existence of Zika virus disease in India. J Infect. 2018 Mar; 76(3):314-317. DOI: 10.1016/j.jinf.2017.09.020. Epub 2017 Oct 5. PMID: 28988896.
    59. *Mourya DT, Yadav PD,Khare A, Khan AH. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues. Indian J Med Res. 2017 Oct; 146(4):459-467. DOI: 10.4103/ijmr.IJMR_974_16. PMID: 29434059; PMCID: PMC5819027. (Review)
    60. *Mourya DT, Viswanathan R, Jadhav SK, Yadav PD,Basu A, Chadha MS. Retrospective analysis of clinical information in Crimean-Congo haemorrhagic fever patients: 2014-2015, India. Indian J Med Res. 2017 May; 145(5):673-678. DOI: 10.4103/ijmr.IJMR_65_16. PMID: 28948959; PMCID: PMC5644303. (Review)
    61. Yadav PD,Chaubal GY, Shete AM, *Mourya DT. A mini-review of Bunyaviruses recorded in India. Indian J Med Res. 2017 May; 145(5):601-610. DOI: 10.4103/ijmr.IJMR_1871_15. PMID: 28948950; PMCID: PMC5644294. (Review)
    62. Patil DY, Yadav PD,Shete AM, Nuchina J, Meti R, Bhattad D, Someshwar S, *Mourya DT. Occupational exposure of cashew nut workers to Kyasanur Forest disease in Goa, India. Int J Infect Dis. 2017 Aug; 61:67-69. DOI: 10.1016/j.ijid.2017.06.004. Epub 2017 Jun 13. PMID: 28627428.
    63. *Yadav PD, Deoshatwar A, Shete A, Tandale B, Patil D, Dalal S, Mourya D. Serosurvey of Malsoor virus among Rousettus leschenaulti bat & human population residing nearby Robber's cave, Mahabaleshwar, Maharashtra, India. Indian J Med Res. 2017 Oct; 146(4):545-547. DOI: 10.4103/ijmr.IJMR_301_16. PMID: 29434071; PMCID: PMC5819039.
    64. *Yadav PD,Shete AM, Nyayanit DA, Albarino CG, Jain S, Guerrero LW, Kumar S, Patil DY, Nichol ST, Mourya DT. Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India. J Gen Virol. 2018 Aug; 99(8):991-1000. DOI: 10.1099/jgv.0.001102. Epub 2018 Jun 25. Erratum in: J Gen Virol. 2019 Sep; 100(9):1340. PMID: 29939123.
    65. *Arunkumar G, Chandni R, Mourya DT, Singh SK, Sadanandan R, Sudan P, Bhargava B. Nipah Investigators People and Health Study Group. Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018. J Infect Dis. 2019 May 24; 219(12):1867-1878. DOI: 10.1093/infdis/jiy612. PMID: 30364984.
    66. *Mourya DT, Gokhale MD, Majumdar TD, Yadav PD, Kumar V, Mavale MS. Experimental Zika virus infection in Aedes aegypti: Susceptibility, transmission & co-infection with dengue & chikungunya viruses. Indian J Med Res. 2018 Jan; 147(1):88-96. DOI: 10.4103/ijmr.IJMR_1142_17. PMID: 29749366; PMCID: PMC5967223.
    67. Shil P, Yadav PD, Patil AA, Balasubramanian R, *Mourya DT. Bioinformatics characterization of envelope glycoprotein from Kyasanur Forest disease virus. Indian J Med Res. 2018 Feb; 147(2):195-201. DOI: 10.4103/ijmr.IJMR_1445_16. PMID: 29806609; PMCID: PMC5991130.
    68. *Yadav PD, Kumar V, Kumar S, Mote CS, Majumdar TD, Gokhale M, Kore P, Mourya DT. Zika virus Pathogenesis in Infant Mice after Natural Transmission by the Bite of Infected Mosquitoes. Intervirology. 2017; 60(6):227-234. DOI: 10.1159/000486841. Epub 2018 Mar 29. PMID: 29597193.
    69. Sadanandane C, Gokhale MD, *Elango A, Yadav PD,Mourya DT, Jambulingam P. Prevalence and spatial distribution of Ixodid tick populations in the forest fringes of Western Ghats reported with human cases of Kyasanur forest disease and monkey deaths in South India. Exp Appl Acarol. 2018 May; 75(1):135-142. DOI: 10.1007/s10493-018-0223-5. Epub 2018 Mar 28. PMID: 29594846.
    70. Yadav PD, Sudeep A, Gokhale M, Pawar S, Shete A, Patil D, Kumar V, Lakra R, Sarkale P, Nichol S, *Mourya D. Circulation of Nipah virus in Pteropus giganteus bats in northeast region of India, 2015. Indian J Med Res. 2018 Mar; 147(3):318-320. DOI: 10.4103/ijmr.IJMR_1488_16. PMID: 29923524; PMCID: PMC6022392.
    71. Chaubal G, Sarkale P, Kore P, *Yadav PD. Development of single step RT-PCR for detection of Kyasanur forest disease virus from clinical samples. Heliyon. 2018 Mar 1; 4(2):e00549. DOI: 10.1016/j.heliyon.2018.e00549. PMID: 29560461; PMCID: PMC5857640.
    72. Yadav PD,Albariño CG, Nyayanit DA, Guerrero L, Jenks MH, Sarkale P, Nichol ST, Mourya DT. Equine Encephalosis Virus in India, 2008. Emerg Infect Dis. 2018 May; 24(5):898-901.DOI: 10.3201/eid2405.171844. PMID: 29664366; PMCID: PMC5938759.
    73. Whitmer SLM, *Yadav PD,Sarkale P, Chaubal GY, Francis A, Klena J, Nichol ST, Stroher U, Mourya DT. Characterization of Unknown Orthobunya-Like Viruses from India. Viruses. 2018 Aug 24; 10(9):451.DOI: 10.3390/v10090451. PMID: 30149496; PMCID: PMC6165560.
    74. Sahay RR, Yadav PD, Majumdar T, Patil S, Sarkale P, Shete AM, Chaubal G, Dange VR, Patil S, Nyayanit DA, Shastri J, Mourya DT. Clinico-epidemiological investigation on Varicella Zoster Virus indicates multiple clade circulation in Maharashtra state, India. Heliyon. 2018 Aug 28; 4(8):e00757. DOI: 10.1016/j.heliyon.2018.e00757. PMID: 30175265; PMCID: PMC6118100.
    75. Bharadwaj SD, Sahay RR, Yadav PD,Dhanawade S, Basu A, Meena VK, George S, Damle R, *Sapkal GN. Acute Encephalitis with Atypical Presentation of Rubella in Family Cluster, India. Emerg Infect Dis. 2018 Oct; 24(10):1923-1925. DOI: 10.3201/eid2410.180053. PMID: 30226166; PMCID: PMC6154155.
    76. Munivenkatappa A, *Yadav PD,Nyayanit DA, Majumdar TD, Sangal L, Jain S, Sinha DP, Shrivastava A, Mourya DT. Molecular diversity of Coxsackievirus A10 circulating in the southern and northern region of India [2009-17]. Infect Genet Evol. 2018 Dec; 66:101-110. DOI: 10.1016/j.meegid.2018.09.004. Epub 2018 Sep 12. PMID: 30217658.
    77. *Yadav PD, Patil DY, Mourya DT. Positivity of dengue and chikungunya among Crimean-Congo hemorrhagic fever-negative cases in India: 2013-2016. J Infect Public Health. 2018 Nov-Dec; 11(6):900-901. DOI: 10.1016/j.jiph.2018.09.001. Epub 2018 Sep 18. PMID: 30241948.
    78. Munivenkatappa A, Sahay RR, Yadav PD, Viswanathan R, *Mourya DT. Clinical & epidemiological significance of Kyasanur forest disease. Indian J Med Res. 2018 Aug; 148(2):145-150. DOI: 10.4103/ijmr.IJMR_688_17. PMID: 30381537; PMCID: PMC6206778.
    79. Yadav PD, Sahay RR, Mourya DT. Detection of Kyasanur forest disease in newer areas of Sindhudurg district of Maharashtra State. Indian J Med Res. 2018 Oct; 148(4):453-455. DOI: 10.4103/ijmr.IJMR_1292_17. PMID: 30666009; PMCID: PMC6362715.
    80. Yadav PD,Mourya DT (2018) Shrew-borne Thottapalayam Virus: An Indian Perspective. J Emerg Dis Virol 4(1): DOI: 10.16966/2473-1846.140. (Review)
    81. Yadav PD,Nyayanit DA, Shete AM, Jain S, Majumdar TP, Chaubal GY, Shil P, Kore PM, Mourya DT. Complete genome sequencing of Kaisodi virus isolated from ticks in India belonging to Phlebovirus genus, family Phenuiviridae. Ticks Tick Borne Dis. 2019 Jan; 10(1):23-33. DOI: 10.1016/j.ttbdis.2018.08.012. Epub 2018 Aug 28. PMID: 30181094.
    82. Gurav YK, Yadav PD, Gokhale MD, Chiplunkar TR, Vishwanathan R, Patil DY, Mourya DT et al.Kyasanur Forest Disease Prevalence in Western Ghats Proven and Confirmed by Recent Outbreak in Maharashtra, India, 2016. Vector Borne Zoonotic Dis. 2018 Mar; 18(3):164-172. DOI: 10.1089/vbz.2017.2129. Epub 2018 Jan 16. PMID: 29336707.
    83. Shete AM, Yadav PD, Kumar V, Nikam T, Mehershahi K, Kokate P, Patil D, Mourya DT. Development of polymerase chain reaction-based diagnostic tests for detection of Malsoor virus & adenovirus isolated from Rousettus species of bats in Maharashtra, India. Indian J Med Res. 2017 Jan; 145(1):90-96. DOI: 10.4103/ijmr.IJMR_1447_15. PMID: 28574020; PMCID: PMC5460580.
    84. Mourya DT, Ullas PT, and Yadav PD. Molecular pathogenesis of Nipah virus infection. In; MOLECULAR FOOD MICROBIOLOGY.CRC Press; Chapter 40; 3rd Edition, First Published2021, Imprint CRC Press, Pages13, eBook ISBN9781351120388.
    85. Mourya DT, Yadav PD,Gurav YK, Pardeshi PG, Shete AM, Jain R, Raval DD, Upadhyay KJ, Patil DY. Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India. BMC Infect Dis. 2019 Feb 1; 19(1):104. DOI: 10.1186/s12879-019-3740-x. PMID: 30709372; PMCID: PMC6359815.
    86. Mourya DT, Yadav PD,Nyayanit DA, Majumdar TD, Jain S, Sarkale P, Shete A. Characterization of a strain of quaranfil virus isolated from soft ticks in India. Is quaranfil virus an unrecognized cause of disease in human and animals. Heliyon. 2019 Mar 20; 5(3):e01368. DOI: 10.1016/j.heliyon.2019.e01368. PMID: 30957047; PMCID: PMC6431747.
    87. Mourya DT, Yadav PD,Ullas PT, Bhardwaj SD, Sahay RR, Chadha MS, Shete AM, Jadhav S, Gupta N, Gangakhedkar RR, Khasnobis P, Singh SK. Emerging/re-emerging viral diseases & new viruses on the Indian horizon. Indian J Med Res. 2019 Apr; 149(4):447-467. DOI: 10.4103/ijmr.IJMR_1239_18. Erratum in: Indian J Med Res. 2019 May; 149(5):688. PMID: 31411169; PMCID: PMC6676836. (Review)
    88. Yadav PD, Malhotra B, Sapkal G, Nyayanit DA, Deshpande G, Gupta N, Mourya DT et al. Zika virus outbreak in Rajasthan, India in 2018 was caused by a virus endemic to Asia. Infect Genet Evol. 2019 Apr; 69:199-202. DOI: 10.1016/j.meegid.2019.01.026. Epub 2019 Jan 28. PMID: 30703541.
    89. Kumar CPG, Sugunan AP, Yadav PD,Kurup KK, Aarathee R, Murhekar MV et al. Infections among Contacts of Patients with Nipah Virus, India. Emerg Infect Dis. 2019 May; 25(5):1007-1010. DOI: 10.3201/eid2505.181352. PMID: 31002050; PMCID: PMC6478200.
    90. Mourya D, Yadav PD, Rout M, Pattnaik B, Shete A, Patil D. Absence of Nipah virus antibodies in pigs in Mizoram State, North East India. Indian J Med Res. 2019 May; 149(5):677-679. DOI: 10.4103/ijmr.IJMR_1086_18. PMID: 31417037; PMCID: PMC6702692.
    91. *Yadav PD,Shete AM, Kumar GA, Sarkale P, Sahay RR, Radhakrishnan C, et al. Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018. Emerg Infect Dis. 2019 May; 25(5):1003-1006. DOI: 10.3201/eid2505.181076. PMID: 31002049; PMCID: PMC6478210.
    92. Balasubramanian R, Yadav PD,Sahina S, ArathyNadh V. Distribution and prevalence of ticks on livestock population in endemic area of Kyasanur forest disease in Western Ghats of Kerala, South India. J Parasit Dis. 2019 Jun; 43(2):256-262. DOI: 10.1007/s12639-019-01086-7. Epub 2019 Jan 22. PMID: 31263331; PMCID: PMC6570721.
    93. Yadav PD, Whitmer SLM, Sarkale P, Fei Fan Ng T, Goldsmith CS, Nyayanit DA, Mourya DT et al. Characterization of Novel Reoviruses Wad Medani Virus (Orbivirus) and Kundal Virus (Coltivirus) Collected from Hyalomma anatolicum Ticks in India during Surveillance for Crimean Congo Hemorrhagic Fever. J Virol. 2019 Jun 14; 93(13):e00106-19. DOI: 10.1128/JVI.00106-19. PMID: 30971476; PMCID: PMC6580951.
    94. Mourya DT, Yadav PD, Sudeep AB, Gokhale MD, Gupta N, Gangakhedkar RR, Bhargava B. Spatial Association Between a Nipah Virus Outbreak in India and Nipah Virus Infection in Pteropus Bats. Clin Infect Dis. 2019 Jul 2; 69(2):378-379. DOI: 10.1093/cid/ciy1093. PMID: 30590538.
    95. Nyayanit DA, Sahay RR, Sakpal GN, Shete AM, Chaubal GC, Sarkale P, Srivastava R, Mohandas S, *Yadav PD. Identification and phylogenetic analysis of herpes simplex virus-1 from clinical isolates in India. Microbiol. 2019 Jul 26; 1(6):e000047. DOI: 10.1099/acmi.0.000047. PMID: 32974534; PMCID: PMC7470303.
    96. *Yadav PD,Pardeshi PG, Patil DY, Shete AM, Mourya DT. Persistence of IgG antibodies in survivors of Crimean Congo hemorrhagic fever virus infection, India. J Infect Public Health. 2019 Jul-Aug; 12(4):598-599. DOI: 10.1016/j.jiph.2019.04.005. Epub 2019 Apr 23. PMID: 31027886.
    97. *Yadav PD,Gurav YK, Shete AM, Jain R, Nyayanit DA, Pardeshi PG, Viswanathan R, Chiplunkar TR, Awate P, Majumdar TP, Sahay RR, Mourya DT. Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease. Indian J Med Res. 2019 Aug; 150(2):186-193. DOI: 10.4103/ijmr.IJMR_1929_17. PMID: 31670274; PMCID: PMC6829781.
    98. Sarkale P, Shrivastava A, Mohandas S, Patil SL, Kore P, Soman V, *Yadav PD. Growth Kinetics of Kyasanur Forest Disease Virus in Mammalian Cell Lines and Development of Plaque Reduction Neutralization Test. Vector Borne Zoonotic Dis. 2019 Aug;19(8):630-636. DOI: 10.1089/vbz.2018.2405. Epub 2019 Apr 17. PMID: 30994413.
    99. Mourya DT, Yadav PD, Mohandas S, Kadiwar RF, Vala MK, Saxena AK, Shete-Aich A, Gupta N, Purushothama P, Sahay RR, Gangakhedkar RR, Mishra SCK, Bhargava B. Canine Distemper Virus in Asiatic Lions of Gujarat State, India. Emerg Infect Dis. 2019 Nov; 25(11):2128-2130. DOI: 10.3201/eid2511.190120. PMID: 31625861; PMCID: PMC6810198.
    100. Bhardwaj SD, Potdar VA, Yadav PD, Chaudhary ML, Chadha MS, Mourya D. A case report of the enterovirus-D68 associated severe acute respiratory illness in a pediatric case from India. J Infect Public Health. 2019 Nov-Dec; 12(6):900-903. DOI: 10.1016/j.jiph.2019.04.013. Epub 2019 May 10. PMID: 31085132; PMCID: PMC7102825.
    101. Potdar V, Hinge D, Satav A, Simoes EAF, Yadav PD, Chadha MS. Laboratory-Confirmed Avian Influenza A (H9N2) Virus Infection, India, 2019. Emerg Infect Dis. 2019 Dec; 25(12):2328-2330. DOI: 10.3201/eid2512.190636. PMID: 31742537; PMCID: PMC6874269.
    102. Yadav PD,Chaubal G, Jena S, Shil P, Mourya DY. Assessment of NS1 protein as an early diagnostic marker for Kyasanur forest disease virus. J Vector Borne Dis. 2019 Jul-Sep; 56(3):212-220. DOI: 10.4103/0972-9062.289392. PMID: 32655070. 103. From crisis to opportunity, india’s response to the Nipah Virus outbreak, Kerala 2018/2019 released by ICMR-HQ on 7th December 2019. ICMRBooklet
    104. Mourya DT, Yadav PD et al. General Guidelines on “Establishment of Biosafety Level-3 Laboratory” was released by the Secretary DHR and DG ICMR during the 2nd meeting of the Regional Platform on Infectious Diseases of the Public Health Importance in WHO SEAR in Dec 2019. [Policy document].
    105. Mukhopadhyay L, Yadav PD, Gupta N, Mohandas S, Patil DY, Shete-Aich A, Panda S, Bhargava B, Bhatia R, Sharma YP, Agstam S. Systematic Review: Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates. Indian J Med Res. 2021(153):93-114. DOI: 10.4103/ijmr.IJMR_4431_20. (Review)
    106. Tripathi S, Bhati R, Gopalakrishnan M, Bohra GK, Tiwari S, Panda S, Sahay RR, Yadav PD, Nag VL, Garg MK. Clinical profile and outcome of patients with Crimean Congo haemorrhagic fever: a hospital based observational study from Rajasthan, India. Trans R Soc Trop Med Hyg. 2020 Sep 1; 114(9):650-656. DOI: 10.1093/trstmh/traa014. PMID: 32286662.
    107. Gupta N, Potdar V, Yadav PD, Patil DY, Sapkal G. Preparedness of public health-care system for Zika virus outbreak: An Indian perspective. J Infect Public Health. 2020: 13(7): 949-955. DOI:https://doi.org/10.1016/j.jiph.2020.03.016. (Review) 108. Malhotra B, Gupta V, Sharma P, Singh R, Sharma H, Vyas M, Mathur RP, Mathur VK, Meena D, Malhotra H, Yadav PD, et al. Clinico-epidemiological and genomic profile of first Zika Virus outbreak in India at Jaipur city of Rajasthan state. J Infect Public Health. 2020 Dec; 13(2020) 1920-1926. DOI:10.1016/j.jiph.2020.10.006. PMID: 33172818.
    109. Kumar JS, Yadav PD,Shete AM, Majumdar T, Patil S, *Dash PK. Development and Evaluation of Reverse Transcription Loop-Mediated Isothermal Amplification for Rapid and Real-Time Detection of Kyasanur Forest Disease Virus. Int J Infect Dis. 2021 Jan 21:S1201-9712(21)00052-7. DOI: 10.1016/j.ijid.2021.01.041. Epub ahead of print. PMID: 33486011.
    110. Mourya DT, Sapkal G, Yadav PD, M Belani SK, Shete A, Gupta N. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):172-176. DOI: 10.4103/ijmr.IJMR_763_20. PMID: 32242878; PMCID: PMC7357401. (Review)
    111. *Yadav PD,Potdar VA, Choudhary ML, Nyayanit DA, Agrawal M, Jadhav SM, Majumdar TD, Shete-Aich A, Basu A, Abraham P, Cherian SS. Full-genome sequences of the first two SARS-CoV-2 viruses from India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):200-209. DOI: 10.4103/ijmr.IJMR_663_20. PMID: 32242873; PMCID: PMC7258756.
    113. Yadav PD,Shete-Aich A, Nyayanit DA, Pardeshi P, Majumdar T, Mourya DT et al. Detection of coronaviruses in Pteropus & Rousettus species of bats from different States of India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):226-235. DOI: 10.4103/ijmr.IJMR_795_20. PMID: 32317409; PMCID: PMC7366549.
    114. Potdar V, Cherian SS, Deshpande GR, Ullas PT, *Yadav PD, et al. Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):255-260. DOI: 10.4103/ijmr.IJMR_1058_20. PMID: 32362650; PMCID: PMC7366550.
    115. Sarkale P, Patil S, *Yadav PD,Nyayanit DA, Sapkal G, Baradkar S, Lakra R, Shete-Aich A, et al First isolation of SARS-CoV-2 from clinical samples in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):244-250. DOI: 10.4103/ijmr.IJMR_1029_20. PMID: 32362649; PMCID: PMC7366528.
    116. Mohandas S, Jain R, *Yadav PD,Shete-Aich A, Sarkale P, Kadam M, Kumar A, Deshpande G, Baradkar S, Patil S, Sapkal G, Mali D, Salve M, Patil D, Majumdar T, Suryawanshi A, Kaushal H, Lakra R, Dighe H, Gupta N, Abraham P, Gangakhedkar RR. Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection. Indian J Med Res. 2020 May; 151(5):479-482. DOI: 10.4103/ijmr.IJMR_2235_20. PMID: 32611917; PMCID: PMC7530454.
    117. Gupta N, Potdar V, Praharaj I, Giri S, Sapkal G, *Yadav PD, Choudhary ML, et al P. Authors' response. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020 May; 151(5):496. DOI: 10.4103/0971-5916.286255. PMID: 32611921; PMCID: PMC7530453. (Review)
    118. Sapkal G, Shete-Aich A, Jain R, *Yadav PD,Sarkale P, et al Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Indian J Med Res. 2020 May; 151(5):444-449. DOI: 10.4103/ijmr.IJMR_2232_20. PMID: 32611915; PMCID: PMC7530443.
    119. Potdar V, Choudhary ML, Bhardwaj S, Ghuge R, Sugunan AP, Gurav Y, Yadav PD, etal. Respiratory virus detection among the overseas returnees during the early phase of COVID-19 pandemic in India. Indian J Med Res. 2020 May; 151(5):486-489. DOI: 10.4103/ijmr.IJMR_638_20. PMID: 32474556; PMCID: PMC7530434.
    120. Murhekar MV, Bhatnagar T, Selvaraju S, […….] Yadav PD et al. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian J Med Res. 2020 Jan 1; 152(1):48. DOI: 10.4103/ijmr.IJMR_3290_20. PMID: 32952144; PMCID: PMC7853249.
    121. Deshpande GR, Sapkal GN, Tilekar BN, Yadav PD,Gurav Y, Gaikwad S, Kaushal H, Deshpande KS, Kaduskar O, Sarkale P, Baradkar S, Suryawanshi A, Lakra R, Sugunan AP, Balakrishnan A, Abraham P, Salve P. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):82-87.DOI: 10.4103/ijmr.IJMR_2382_20. PMID: 32859866; PMCID: PMC7853248.
    122. Nyayanit DA, Sarkale P, Baradkar S, Patil S, *Yadav PD,Shete-Aich A, Kalele K, Gawande P, Majumdar T, Jain R, Sapkal G. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):70-76. DOI: 10.4103/ijmr.IJMR_2257_20. PMID: 32773420; PMCID: PMC7853258.
    123. Jain P, Prakash O, Nyayanit DA, Verma AK, Yadav PD, Khan DN, Prakash S, Mishra H, Reddy H, Agarwal A, Bhatt MB, Jain A. Identification of SARS-CoV-2 clusters from symptomatic cases in India. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):111-115. DOI: 10.4103/ijmr.IJMR_2411_20. PMID: 32859867; PMCID: PMC7853268.
    124. Nyayanit DA, *Yadav PD, Kharde R, Shete-Aich A. Quasispecies analysis of the SARS-CoV-2 from representative clinical samples: A preliminary analysis. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):105-107. DOI: 10.4103/ijmr.IJMR_2251_20. PMID: 32773417; PMCID: PMC7853256.
    125. Sahay RR, Dhandore S, **Yadav PD, Chauhan A, Bhatt L, Garg V, Gupta N, Nyayanit DA, Shete AM, Singh R, Patil S, Sharma H, Meena D, Gupta J, Gawande P, Kalele K, Jain R, Mali D, Malhotra B, Nag V, Khatri PK, Kaur H, Vijay N, Singh S, Gopalakrishnan M. Detection of African genotype in Hyalomma tick pools during Crimean Congo hemorrhagic fever outbreak, Rajasthan, India, 2019. Virus Res. 2020 Sep; 286:198046. DOI: 10.1016/j.virusres.2020.198046. Epub 2020 Jun 4. PMID: 32505728.
    126. Agarwal A, Mukherjee A, Kumar G, Chatterjee P, [……] Yadav PD et al. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). BMJ. 2020 Oct 22; 371:m3939. DOI: 10.1136/bmj.m3939. Erratum in: BMJ. 2020 Nov 3; 371:m4232. PMID: 33093056; PMCID: PMC7578662.
    127. Jain R, Sarkale P, Mali D, Shete AM, Patil DY, Majumdar T, Suryawanshi A, Patil S, Mohandas S, *Yadav PD. Inactivation of SARS-CoV-2 by gamma irradiation. Indian J Med Res. 2020 Nov 27. DOI: 10.4103/ijmr.IJMR_2789_20. Epub ahead of print. PMID: 33243957.
    128. Basawarajappa SG, Rangaiah A, Padukone S, Yadav PD, Gupta N, *Shankar SM. Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019. Indian J Med Res. 2020 Nov 4. DOI: 10.4103/ijmr.IJMR_2363_20. Epub ahead of print. PMID: 33146156.
    129. Saxena VK, Pawar SD, Qureshi THIH, Surve P, *Yadav PD, Nabi F, Mendadkar R. Isolation and molecular characterization of coxsackievirus A6 and coxsackievirus A16 from a case of recurrent Hand, Foot and Mouth Disease in Mumbai, Maharashtra, India, 2018. Virus disease. 2020 Mar; 31(1):56-60. DOI: 10.1007/s13337-020-00567-1. Epub 2020 Feb 7. PMID: 32206699; PMCID: PMC7085487.
    130. Sahay RR, *Yadav PD, Gupta N, Shete AM, Radhakrishnan C, etal. Experimental learnings from the Nipah virus outbreaks in Kerala towards containment of infectious public health emergencies in India. Epidemiol Infect. 2020 Apr 23; 148:e90. DOI: 10.1017/S0950268820000825. PMID: 32321607; PMCID: PMC7253795.
    131. Patil DR, *Yadav PD,Shete A, Chaubal G, Mohandas S, Sahay RR, Jain R, Mote C, Kumar S, Kaushal H, Kore P, Patil S, Majumdar T, Fulari S, Suryawanshi A, Kadam M, Pardeshi PG, Lakra R, Sarkale P, Mourya DT. Study of Kyasanur forest disease viremia, antibody kinetics, and virus infection in target organs of Macaca radiata. Sci Rep. 2020 Jul 28; 10(1):12561. DOI: 10.1038/s41598-020-67599-x. PMID: 32724103; PMCID: PMC7387489.
    132. Shete Anita, Nyayanit DA, Sarkale S, Baradkar S, Patil S, *Yadav PD,Gawande P, Majumdar T, et al Proactive preparedness for Cat Que virus: An Orthobunyavirus existing in India. Indian J Med Res. 2020, 151 (6): 571-577.
    133. Joshi P, Yadav PD,Mourya D, Sahare L, Ukey M, Khedekar R, Patil D, *Barde PV. Laboratory surveillance of chikungunya in Madhya Pradesh, India (2016-2017). Indian J Med Res. 2020 Jan; 151(1):87-92.DOI: 10.4103/ijmr.IJMR_204_19. PMID: 32134019; PMCID: PMC7055169.
    134. Yadav PD, Mauldin MR, Nyayanit DA, Albariño CG, Sarkale P, Shete A, Guerrero LW, Nakazawa Y, Nichol ST, *Mourya DT. Isolation and phylogenomic analysis of buffalopox virus from human and buffaloes in India. Virus Res. 2020 Feb; 277:197836. DOI: 10.1016/j.virusres.2019.197836. Epub 2019 Dec 9. PMID: 31821842.
    135. Munivenkatappa A, *Yadav PD, Swetha K, Jayaswamy M, Nyayanit DA, Sahay RR, Basavaraj TJ. SARS-CoV-2 & influenza A virus co-infection in an elderly patient with pneumonia. Indian J Med Res. 2021 Jan 12. DOI: 10.4103/ijmr.IJMR_2711_20. Epub ahead of print. PMID: 33433500.
    136. Author’s Response: Labanya Mukhopadhyay, Pragya D. Yadav, Nivedita Gupta, Sreelekshmy Mohandas, Deepak Y. Patil, Anita Shete Aich, Samiran Panda & Balram Bhargava. Heterogeneity in protocols for bronchoalveolar lavage & sub-genomic RNA evaluation in non-human primate studies of SARS-CoV-2 vaccine candidates' evaluation. Indian J Med Res DOI:10.4103/ijmr.IJMR_4925_20 PMID:34145087
    137. Boehm, E., Yadav, P., & Kumar, S. (2021). Reviews of “SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination.” Rapid Reviews COVID-19. https://doi.org/10.1162/2e3983f5.61a248f5 138. Ella R, *Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav PD, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 Jan 21:S1473-3099(20)30942-7. DOI: 10.1016/S1473-3099(20)30942-7. Epub ahead of print. PMID: 33485468; PMCID: PMC7825810.
    139. Mohandas S, *Yadav PD, Shete-Aich A, Abraham P, Vadrevu KM, Sapkal G, Mote C, Nyayanit D, Gupta N, Srinivas VK, Kadam M, Kumar A, Majumdar T, Jain R, Deshpande G, Patil S, Sarkale P, Patil D, Ella R, Prasad SD, Sharma S, Ella KM, Panda S, Bhargava B. Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model. iScience. 2021 Feb 19; 24(2):102054. DOI: 10.1016/j.isci.2021.102054. Epub 2021 Jan 9. PMID: 33521604; PMCID: PMC7829205.
    140. *Yadav PD, Ella R, Kumar S. [……],*Bhargava B et al. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nat Commun. 12, 1386 (2021). DOI: https://doi.org/10.1038/s41467-021-21639-w
    141. Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U, Sapkal G, Yadav PD. [...], *Vadrevu KM et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 Mar 8.DOI: https://doi.org/10.1016/S1473-3099(21)00070-0.PMID:33705727.PMCID:PMC8221739.
    142. *Yadav PD, Nyayanit DA, Sahay RR, Sarkale P, Pethani J, Patil S, Baradkar S, Potdar V, Patil DY. Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage. J Travel Med; 28(2)2021;02;23. DOI: https://doi.org/10.1093/jtm/taab009.
    143. *Yadav PD, Nyayanit DA, Sahay RR, Shete AM, Majumdar T, Patil S, Patil DY, Gupta N, Kaur H, Aggarwal N, Vijay N, Narayan J, Nikam C, Pethani J. Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India. Travel Med Infect Dis. 2021 Mar 13:102023. DOI:10.1016/j.tmaid.2021.102023. Epub ahead of print. PMID: 33727176; PMCID: PMC7955805.
    144. Sapkal GN, *Yadav PD, Ella R, Deshpande GR, Sahay RR, Gupta N, Vadrevu KM, Abraham P, Panda S, Bhargava B. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. J Travel Med. 2021 Jun 1;28(4):taab051. doi: 10.1093/jtm/taab051. PMID: 33772577; PMCID: PMC8083765.
    145. Mourya DT, Yadav PD, Patil DY, Sahay RR. Experiences of Indian Council of Medical Research with tick-borne zoonotic infections; Kyasanur Forest disease and Crimean Congo hemorrhagic fever in India with one health focus. Indian J Med Res. 2021. DOI:10.4103/ijmr.IJMR_532_21.Corpus ID: 233428738. (Review)
    146. Prasad S, Meena VK, Yadav PD, Sarkale PC, Baradkar S, Cherian S, Abraham P, Basu A. Electron Microscopy Imaging of SARS-CoV-2 at different temperatures. Indian J Med Res. 2021. 2021 May;153(5&6):692-695. doi: 10.4103/ijmr.IJMR_4264_20. PMID: 34145089.
    147. Mohandas S, *Yadav PD, Nyayanit D, Shete A, Sarkale P, Hundekar S, Kumar S, Lole K. Comparison of SARS-CoV-2 Variants of Concern 202012/01 (U.K. Variant) and D614G Variant Transmission by Different Routes in Syrian Hamsters. Vector Borne Zoonotic Dis. 2021 Jul 1. doi: 10.1089/vbz.2021.0032. Epub ahead of print. PMID: 34197265.
    148. Deshpande K, PT Ullas, Kaduskar O, Vijay N, Rakhe A, Vidhate S, KhutwadK, Yadav PD et al.2021. Performance assessment of seven SARS-CoV-2 IgG enzyme linked immunosorbent assays. J Med Virol. 2021 Dec;93(12):6696-6702. doi: 10.1002/jmv.27251. Epub 2021 Aug 10. PMID: 34331713; PMCID: PMC8426713.
    149. *Yadav PD, Sapkal GN, Abraham P, Ella R, Deshpande G, Patil DY, Nyayanit D, Gupta N, Sahay RR, Shete AM, Panda S, Bhargava B, V. Krishna Mohan. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. Clinical Infectious Diseases, 2021;, ciab411, https://doi.org/10.1093/cid/ciab411
    150. *Yadav PD, Sapkal GN, Abraham P, Deshpande G, Nyayanit D, Patil DY, Gupta N, Sahay RR, Shete A, Kumar S, Panda S, Bhargava B. Neutralization Potential of Covishield Vaccinated Individuals Sera Against B.1.617.1, Clinical Infectious Diseases, 2021;, ciab483, https://doi.org/10.1093/cid/ciab483
    151. *Yadav PD, Sapkal GN et al. Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin, Journal of Travel Medicine, Volume 28, Issue 7, October 2021, taab104, https://doi.org/10.1093/jtm/taab104
    152. Sapkal G, *Yadav PD, Ella R, Abraham P, Patil D, Gupta N, Panda S, Bhargava B. Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine Covaxin. Journal of Travel Medicine, 2021;, taab077, https://doi.org/10.1093/jtm/taab077
    153. *Yadav PD, Nyayanit DA, Majumdar T, Patil S, Kaur H, Gupta N, Shete AM, et al. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India. Viruses 2021, 13, 925. https://doi.org/10.3390/v13050925. 154. Cherian S, Potdar V, Jadhav S, Yadav P, Gupta N, Das M, Rakshit P, Singh S, Abraham P, Panda S, Team N. SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India. Microorganisms. 2021 Jul 20;9(7):1542. doi: 10.3390/microorganisms9071542. PMID: 34361977; PMCID: PMC8307577.
    155. Shete A, Mohandas S, Jain R, *Yadav PD. A qualitative IgG ELISA for detection of SARS-CoV-2 specific antibodies in Syrian hamster serum samples. STAR Protoc. 2021 Jun 18;2(2):100573. doi: 10.1016/j.xpro.2021.100573. Epub 2021 May 10. PMID: 33997801; PMCID: PMC8108381.
    156. Gokhale MD, Sreelekshmy M, Sudeep AB, Shete A, Jain R, *Yadav PD. Detection of possible Nipah virus infection in Rousettus leschenaultii and Pipistrellus pipistrellus bats in Maharashtra, India. Journal of Infection and Public Health, Volume 14, Issue 8, 2021; 1010-1012. https://doi.org/10.1016/j.jiph.2021.05.001.
    157. Majumdar T, Shete A, *Yadav PD, Patil S, Mali D, Waghmare A, Gawande P. Point of care real-time polymerase chain reaction-based diagnostic for Kyasanur forest disease. International Journal of Infectious Diseases. 2021 Jul 1; 108:226-30. 158. *Yadav PD, Sapkal GN, Ella R, Sahay RR, Nyayanit DA, Patil DY, Deshpande G, Shete AM, Gupta N, Mohan VK, Abraham P. Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin. J Travel Med. 2021 Oct 11;28(7):taab104. doi: 10.1093/jtm/taab104. PMID: 34230972; PMCID: PMC8344909.
    159. Sapkal G, *Yadav PD, Sahay RR, Deshpande G, Gupta N, Nyayanit DA, Patil DY, Kumar S, Abraham P, Panda S, Bhargava B. Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals. Journal of Travel Medicine, taab119, https://doi.org/10.1093/jtm/taab119.
    160. Sudeep AB, *Yadav PD, Gokhale MD, Balasubramanian R, Gupta N, Shete A, Jain R, Patil S, Sahay RR, Nyayanit DA, Gopale S, Pardeshi PG, Majumdar TD, Patil DR, Sugunan AP, Mourya DT. Detection of Nipah virus in Pteropus medius in 2019 outbreak from Ernakulam district, Kerala, India. BMC Infect Dis. 2021 Feb 9; 21(1):162. DOI: 10.1186/s12879-021-05865-7. PMID: 33563231; PMCID: PMC7871573.
    161. Nyayanit DA, *Yadav PD,Kharde R, Cherian S. Natural Selection Plays an Important Role in Shaping the Codon Usage of Structural Genes of the Viruses Belonging to the Coronaviridae Family. Viruses. 2021; 13(1):3. DOI: https://doi.org/10.3390/v130100
    162. Jeromie Wesley Vivian Thangaraj, Yadav PD, CP Girish Kumar, Anita Shete, Dimpal A. Nyayanit, D Sudha Rani, Abhinendra Kumar, Muthusamy Santhosh Kumar, R Sabarinathan, V Saravana Kumar, M Jagadeesan, Manoj Murhekar, Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021, Journal of Infection, 2021, https://doi.org/10.1016/j.jinf.2021.08.006.
    163. *Yadav PD, Gajanan N Sapkal, Priya Abraham, Gururaj Deshpande, Dimpal A Nyayanit, Deepak Y Patil, Nivedita Gupta, Rima R Sahay, Anita M Shete, Sanjay Kumar, Samiran Panda, Balram Bhargava, Neutralization Potential of Covishield Vaccinated Individuals Sera Against B.1.617.1, Clinical Infectious Diseases, 2021;ciab483, https://doi.org/10.1093/cid/ciab483
    164. Zaman, K., Shankar, P., *Yadav PD, Nyayanit, D., Behera, S., Bhardwaj, P., . . . Kant, R. Molecular epidemiology of a familial cluster of SARS-CoV-2 infection during lockdown period in Sant Kabir Nagar, Uttar Pradesh, India. Epidemiology and Infection, 2021; 1-11. doi:10.1017/S0950268821001989
    165. Brunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram, Dipankar Das, Narasimha Reddy Molugu, Sai D. Prasad, Srinivas V. Kannappa, Krishna M. Ella, Rajaram Ravikrishnan, Amit Awasthi, Jomy Jose, Panduranga Rao, Deepak Kumar, Raches Ella, Priya Abraham, Yadav PD, Gajanan N. Sapkal, Anita Shete-Aich, Gururaj Desphande, Sreelekshmy Mohandas, Atanu Basu, Nivedita Gupta, Krishna Mohan Vadrevu, Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation. iScience, Volume 24, Issue 4, 2021,102298, ISSN 2589-0042,https://doi.org/10.1016/j.isci.2021.102298.
    166. Sahay RR, Shete AM, *Yadav PD, Patil S, Majumdar T, Jain R, et al. (2021) Sequential determination of viral load, humoral responses, and phylogenetic analysis in fatal and non-fatal cases of Crimean-Congo hemorrhagic fever patients from Gujarat, India, 2019. PLoS Negl Trop Dis 15(8):e0009718. https://doi.org/10.1371/journal.pntd.0009718
    167. Patil Deepak Y, Mohandas Sreelekshmy, *Yadav PD. Role of syrian hamsters and nonhuman primates in covid-19 research. Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases. 2021;42(1)DOI : 10.5958/0974-0147.2021.00002.7
    168. Mohandas, S.*Yadav PD. Shete, A. Nyayanit, D. Sapkal, G. Lole, K.; Gupta, N. SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters. Viruses 2021, 13, 1773. https://doi.org/10.3390/v13091773
    169. Gupta S, Gupta N, Yadav PD, Patil DY. Ebola preparedness plan for developing countries: Lessons learned from Ebola outbreaks. J Infect Public Health, 2021 March: 14 (3):293-305.DOI: https://doi.org/10.1016/j.jiph.2020.12.030. (Review)
    170. Ketki Deshpande, Ullas PT, Ojas Kaduskar, Neetu Vijay, Aparna Rakhe, Shankar Vidhate, Kirtee Khutwad, Gururaj Rao Deshpande, Bipin Tilekar, Sanskruti Saka, Kshitija Gadekar, Roshni Patil, Yadav PD, Varsha Potdar, Yogesh Gurav, Priyanka Gupta, Harmanmeet Kaur, Jitendra Narayan, Gajanan Sapkal, Priya Abraham. Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assays JMV https://doi.org/10.1002/jmv.27251
    171. Rajni Kant, Dwivedi Gaurav, Zaman Kamran, […],*Yadav Pragya, et al. Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin, Journal of Travel Medicine, 2021; taab166, https://doi.org/10.1093/jtm/taab166
    172. Yadav PD*, Sahay RR, Sapkal G, Nyayanit D, Shete AM, Deshpande G, Patil DY, Gupta N, Kumar S, Abraham P, Panda S, Bhargava B. Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152. J Travel Med. 2021 Sep 28:taab154. doi: 10.1093/jtm/taab154. Epub ahead of print. PMID: 34581415; PMCID: PMC8500129. 173. Mammen JJ, Kumar S, Thomas L, […]Yadav Pragya, et al. Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial. BMJOpen 2021;11:e050571. doi: 10.1136/bmjopen-2021-050571
    174. Ashok M, *Yadav PD et al., Identification of Phasi Charoen-Like Phasivirus in field collected Aedes aegypti from Karnataka state, India. Vector Borne Zoonotic Dis. 2021 Nov;21(11):900-909. doi: 10.1089/vbz.2021.0011. Epub 2021 Sep 14. PMID: 34520272.
    175. Desphande Gururaj Rao, Kaduskar Ojas, Deshpande Ketki, Bhatt Vaishali, Yadav Pragya, et al. Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2. Int J Infect Dis. 2021 Sep 17;112:103-110. doi: 10.1016/j.ijid.2021.09.024. Epub ahead of print. PMID: 34543771; PMCID: PMC8447547.
    176. Shastri Jayanthi, * Yadav Pragya, Agrawal Sachee. Shete Anita M, et al. Community transmission of SARS-CoV-2 with B.1.1.7 lineage in Mumbai, India. Journal of Microbiology, Immunology and Infection. ,https://doi.org/10.1016/j.jmii.2021.10.004. 177. Munivenkatappa A, Sahay R, *Yadav PD et al A case with SARS-CoV-2 reinfection from India. Indian Journal of Medical Microbiology. 2021 https://doi.org/10.1016/j.ijmmb.2021.09.010
    178. Raches Ella, Siddarth Reddy, William Blackwelder, Varsha Potdar, Pragya Yadav et al. Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a double-blind, randomised, controlled phase 3 trial. The Lancet. Published online November 11, 2021.https://doi.org/10.1016/S0140-6736(21)02000-6
    179. Shete, Anita M.1; Radhakrishnan, Chandni2; Pardeshi, Prachi1; Yadav, Pragya D.1,*; Jain, Rajlaxmi1; Sahay, Rima R.1; Sugunan, A.P.3 Antibody response in symptomatic & asymptomatic Nipah virus cases from Kerala, India, Indian Journal of Medical Research: December 24, 2021 doi: 10.4103/ijmr.IJMR_4388_20
    180. Yadav PD *, Kumar S. Global emergence of SARS-CoV-2 variants: an urgent need of new foresight for improved vaccine efficacy. The Lancet Infectious Diseases. Published online November 23, 2021 https://doi.org/10.1016/S1473-3099(21)00687-3
    181. Deval H, Nyayanit DA, Mishra SK, Yadav PD, Zaman K, Shankar P, MisraBR, Behera SP, Kumar N, Kumar A, Bhardwaj P, Dwivedi GR,Singh R, Shete AM, Pandit P, Pandey AK, Yadav GK, Gupta S, Kumar M Kavathekar A, Singh RS, Prajapati S and Kant R (2022) Genome Sequencing Reveals a Mixed Picture of SARS-CoV-2 Variant of Concern Circulation in Eastern Uttar Pradesh, India. Front. Med. 8:781287. Doi: 10.3389/fmed.2021.781287
    182. Deshpande GR, Bhukya PL, Yadav PD, Salunke A, Patil C, Tilekar BN, Rakhe A, Srivastava R, Gurav YK, Potdar V, Abraham P, Sapkal GN, Comparison of neutralizing antibody response in first and second waves of SARS CoV-2 pandemic in India, Journal of Travel Medicine, 2021;, taab196, https://doi.org/10.1093/jtm/taab196
    183. Author’s Response: Mukhopadhyay L, Yadav PD, Gupta N, Mohandas S, Patil DY, Shete A, Panda S & Bhargava B. Heterogeneity in protocols for bronchoalveolar lavage & sub-genomic RNA evaluation in non-human primate studies of SARS-CoV-2 vaccine candidates’ evaluation. Indian J Med Res, 2021. DOI:10.4103/ijmr.IJMR_4925_20 PMID:34145087
    184. Yadav PD*,Sarkale P, Razdan A, Gupta N, Nyayanit DA, Sahay RR, Potdar V, Patil DY, et al. Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers, Journal of Infection and Public Health, 2021, ISSN 1876-0341,Volume 15, Issue 2, February 2022, Pages 182-186https://doi.org/10.1016/j.jiph.2021.12.011.
    185. Nyayanit, D.A.; Sarkale, P.; Shete-Aich, A.; Kumar, A.; Patil, S.; Majumdar, T.; Baradkar, S.; Gawande, P.; Mohandas, S.; Yadav, P.D Possible Role of Accessory Proteins in the Viral Replication for the 20I/501Y.V1 (B.1.1.7) SARS CoV-2 Variant. Pathogens 2021, 10, 1586. https://doi.org/10.3390/pathogens10121586
    186. Yadav PD*, Mohandas S, Sarkale P, Nyayanit D, Shete A, Sahay R, Potdar V, Baradkar S, Gupta N, Sapkal G, Abraham P, Panda S, Bhargava B. Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model, Journal of Infection and Public Health, 2021, ISSN 1876-0341,Volume 15, Issue 2, February 2022, Pages 164-171https://doi.org/10.1016/j.jiph.2021.12.009
    187. Pragya Yadav*Review for Infection patterns of endemic human coronaviruses in rural households in coastal Kenya. Wellcome Open Research, 13 December 2021.DOI: 10.21956/wellcomeopenres.18181.r46783
    188. Boehm, E., Yadav, P.,& Kumar, S. (2021). Reviews of “SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination.” Rapid Reviews COVID-19. https://doi.org/10.1162/2e3983f5.61a248f5
    189. Yadav, PD.,*Majumdar T, Gupta N, Kumar MA, Shete A, Pardeshi P, Sultana S, Sahay RR, Manoj MN, Patil S, Floura S, Gangakhedkar R, Mourya DT. Standardization & validation of Truenat™ point-of-care test for rapid diagnosis of Nipah. Indian J Med Res. 2021 Dec 2. doi: 10.4103/ijmr.IJMR_4717_20. Epub ahead of print. PMID: 34854433.
    190. Yadav, P.D*. Mendiratta, S.K.; Mohandas, S.; Singh, A.K.; Abraham, P.; Shete, A.; Bandyopadhyay, S.; Kumar, S.; Parikh, A.; Kalita, P.; et al. ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection. Viruses 2021, 13, 2424.https://doi.org/10.3390/v13122424
    191. Mourya DT, Patil DY, Kulkarni R, Belani S, Yadav PD. History of pandemics. In COVID-19 PANDEMIC (History, Science & Society), Publications division, Ministry of Information and Broadcasting, Government of India. 2021. (Book Chapter)
    192. Yadav PD*, Sahay RR, Anukumar B, Mohandas S et al. Nipah virus outbreak in Kerala state, India amidst of COVID-19 pandemic. Frontiers in Public Health. 2022.https://doi.org/10.3389/fpubh.2022.818545
    193. Yadav P.D., Niyas, V.K.M., Arjun, R., Sahay, R.R., Shete, A.M., Sapkal, G.N., Pawar, S., Patil, D.Y., Gupta, N. and Abraham, P. (2022), Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during second wave of COVID-19 pandemic. J Med Virol. https://doi.org/10.1002/jmv.27638
    194. Yadav PD*., Sapkal G, Sahay RR, Potdar V, Deshpande G, Patil DY, Nyayanit DA, Shete AM, Shastri J, Awate P, Malhotra B, Abraham P. Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns. 2022. Journal of Infection. DOI:https://doi.org/10.1016/j.jinf.2022.02.005
    195. *Yadav PD, Gupta N, Potdar V, Mohandas S, Sahay RR, Sarkale P, Shete AM, Razdan A, Patil DY, Nyayanit DA, Joshi Y, Patil S, Majumdar T, Dighe H, Malhotra B, Shastri J, Abraham P. Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens. Viruses. 2022; 14(3):461. https://doi.org/10.3390/v14030461
    196. Sahay Rima , Patil Deepak, Sapkal Gajanan, Deshpande Gururaj, Shete AnitaM , Nyayanit Dimpal , Kumar Sanjay , Dutta Shanta , *Yadav Pragya. SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient sera. 2022. Journal of Infection. February 18, 2022. DOI:https://doi.org/10.1016/j.jinf.2022.02.018
    197. Mourya DT, Yadav PD et al. Re-assessing the biosafety level requirement and defining surveillance need for Kyasanur forest disease virus: Changed paradigm. Indian J Med Res. 2021 Dec 1;154(6):776-80.
    198. Rima Sahay, Yadav PD*et al. Reduced severity of SARS-CoV-2 infection by Kappa VOI (B.1.617.1) in a health care worker post vaccination from Gujarat, Indian J Med Res. 2021. [In press]
    199. Shailesh D. Pawar, Sadhana S. Kode, Sachin S. Keng, Deeksha S. Tare, Ousmane M. Diop, Priya Abraham, Deepa K. Sharma, Lucky Sangal, Pragya D. Yadav, Varsha A. Potdar. Replication of SARS-CoV-2 in cell lines used in public health surveillance programs with special emphasis on biosafety Indian Journal of Medical Research: June 21, 2022 - Volume - Issue - doi: 10.4103/ijmr.ijmr_1448_21.
    200. Sapkal G, Rajni Kant, Dwivedi G, Sahay RR, Yadav PD*, Deshpande GR, Singh R,Nyayanit DA, Patil DY, Shete AM, Zaman K, Chaudhari AK Gupta N, Panda S,Abraham P, Bhargava B. Immune responses against different variants of SARS-CoV-2 including Omicron following six months of administration of heterologous prime-boost COVID-19 vaccine. 2022. Journal of Travel Medicine. 10.1093/jtm/taac033.
    201. Gurav Y, Kalichamy Alagarasu, Yadav PD, Sapkal G, Gokhale M, Parashar D, Jadhav U, Bote M, Kakade M, Nyayanit D, Kumar A, Deshpande GR, Cherian S, Awate P, Abraham P. First case of Zika virus infection during an outbreak of chikungunya in a rural region of Maharashtra state, India. Trans R Soc Trop Med Hyg. 2022 Apr 12:trac022. doi: 10.1093/trstmh/trac022. Epub ahead of print. PMID: 35415761.
    202. Dimpal Amol Nyayanit, Gouri Chaubal, Rima Sahay, Shilpi Jain, Anita Shete,Triparna Majumdar, Anish Shrivastava; Yadav PD*.Molecular characterization of varicella zoster virus isolated from clinical samples in India. Indian J Med Res. 2022. 10.4103/ijmr.IJMR_434_19.
    203. Sapkal G, Yadav PD et al. Understanding dynamics of IgM and IgG antibody in COVID-19 positive patients. Indian J Med Res. 2021. [In press]
    204. Sapkal G, Deshpande GR, Tilekar B, Yadav P, Abraham P, Salunke A, Patil C, Deshpande K, Patil R, Pawar N, Joshi A. Antibody responses to Sputnik Vaccination in naïve and COVID 19-recovered vaccine recipients, India. Journal of travel medicine. 2022 Apr;29(3):taac040.
    205. Thangaraj JW, Kumar MS, Kumar CG, Yadav P, Rani DS, Karunakaran T, Murhekar M. Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India. Frontiers in Public Health. 2022;10.
    206. Mohandas S, Yadav PD, Sapkal G, Shete AM, Deshpande G, Nyayanit DA, Patil D, Kadam M, Kumar A, Mote C, Jain R. Pathogenicity of SARS-CoV-2 Omicron in Syrian hamsters and its neutralization with different Variants of Concern. eBiomedicine. April 08, 2022DOI:https://doi.org/10.1016/j.ebiom.2022.103997
    207. Mohandas S, Yadav PD, Shete A, Nyayanit D, Jain R, Sapkal G, Mote C. Protective immunity of the primary SARS-CoV-2 infection reduces disease severity post re-infection with Delta variants in Syrian hamsters. Viruses. 2022 Mar 13;14(3):596. 208. Shrivastava N, Kumar JS, *Yadav PD, Sharma S, Shete AM, Jain R, Shrivastava A, Dash PK. Development and evaluation of indirect antibody ELISA assay for early diagnosis and surveillance of Crimean-Congo hemorrhagic fever infection in humans. Virus Research. 2022 Feb 18:198717.
    209. *Yadav PD, Nyayanit DA, Gupta N, Shastri JS, Sahay RR, Patil DY, et al. Detection and isolation of SARS-CoV-2 Eta variant from the international travellers and local residents of India. Journal of Medical Virology. 2022. https://doi.org/10.1002/jmv.27676.
    210. Yadav PD, Gupta N, Patil DY, Sahay RR, Shete AM, Abraham P. Regional Manual for the Laboratory Diagnosis of Nipah Virus. World Health Organization. 2022. (Manual)
    211. Deshpande GR, Yadav PD, Abraham P, Nyayanit DA, Sapkal GN, Shete AM, Gupta N, Vadrevu KM, Ella R, Panda S, Bhargava B. Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against Alpha, Beta, Delta and Omicron variants of concern. Journal of Travel Medicine. 2022 Apr;29(3):taac039.
    212. Bhatnagar Tarun, Chaudhri Sirshendu, Ponnaih Manickam, *Yadav PD. et al. Effectiveness of BBV152/Covaxin and AZD1222/Covishield Vaccines Against Severe COVID-19 and B.1.617.2/Delta Variant in India, 2021: A Multi-Centric Hospital-Based Case-Control Study. Journal of Travel Medicine. 2022
    213. Labanya Mukhopadhyay, Gupta N, *Yadav PD, Neeraj Agrawal. Neutralization assays for SARS-CoV-2: Implications for assessment of protective efficacy of COVID-19 vaccines. Indian J Med Res. 2022 April 29, 2022 - doi: 10.4103/ijmr.ijmr_2544_21
    214. *Yadav PD .Advancement in Biomarker Research. Insight from Industry Experts. Biospectrum. The Buisness of Bio&Health Sciences.20, 1: 2022 pp64.
    215. World Health Organization. (‎2022)‎. Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing: interim guidance, 9 March 2022. World Health Organization. https://apps.who.int/iris/handle/10665/352350 [Member of Guideline development group]
    216. Gokhale M, Sudeep AB, Mathapati B, Balasubramanian R, Ullas PT, Mohandas S, Patil DR, Shete AM, Gopale S, Sawant P, Jain R and Yadav PD. Serosurvey for Nipah virus in bat population of southern part of India. Comparative Immunology, Microbiology and Infectious Diseases. 2022 Jun 1; 85:101800.
    217. *Yadav PD, Sapkal GN, Sahay RR, Patil DY, Agrawal S, Adsul B, Tripathy S, Deshpande GR, Nyayanit DA, Shete AM, Shastri J. Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination. Journal of Infection. 2022 Apr 21.
    218. Sahay RR, Patil DY, Sapkal GN, Deshpande GR, Shete AM, Nyayanit DA, Kumar S, *Yadav PD. SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera. Journal of Infection. 2022 Apr 1;84(4):e36-8. 219. Pandit P, Bhatt P, Sahay RR, Joshi Y, Patil DY, *Yadav PD. A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional. Journal of Infection. 2022 Apr 18. DOI:https://doi.org/10.1016/j.jinf.2022.04.023
    220. Gurav YK, Alagarasu K, Yadav PD, Sapkal G, Gokhale M, Parashar D, Jadhav U, Bote M, Kakade M, Nyayanit D, Kumar A. First case of Zika virus infection during an outbreak of chikungunya in a rural region of Maharashtra state, India. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2022 Apr 12.
    221. *Yadav PD, Sahay RR, Agrawal S, Shete A, Adsul B, Tripathy S, Nyayanit DA, Manrai M, Patil DY, Kumar S, Marwah V. Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021. Journal of Infection. 2022 Apr 7.
    222. Kumar JS, Parida M, Shete AM, Majumdar T, Patil S, Yadav PD, Dash PK. Development of a Reverse Transcription Loop-Mediated Isothermal Amplification [RT-LAMP] as a early rapid detection assay for Crimean Congo Hemorrhagic Fever virus. Acta Tropica. 2022 Apr 1:106435.
    223. *Yadav PD, Sapkal GN, Sahay RR, Patil DY, Deshpande GR, Jain R, Nyayanit DA, Shete AM, Suryawanshi A, Nandapurkar A, Gurav YK. Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees. Journal of Infection. 2022 Mar 19.
    224. Murali S, Sakthivel M, Kamaraj P, Venkataswamy V, Thangaraj JW, Shete A, John A, Arjun J, CP GK, Yadav PD, Sahay R. Effectiveness of ChAdOx1 nCoV-19 Corona Virus Vaccine (CovishieldTM) in preventing SARS-CoV2 infection, Chennai, Tamil Nadu, India, 2021. Vaccines. 2022, 10, 970.
    225. Yadav PD, Kaur H, Gupta N, Sahay RR, Sapkal GN, Shete AM, Deshpande GR, Mohandas S, Majumdar T, Yadav S, Pandit P. Zika a vector borne disease detected in newer states of India amidst the COVID-19 pandemic. Frontiers in Microbiology. 2022:1852.
    226. Vadrevu KrishnaMohan , Ganneru Brunda , Reddy Siddharth , Jogdand Harsh , Dugyala Raju, Praturi Usha , Sapkal GajananN , Yadav Pragya , et al. Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial medRxiv 2022.01.05.22268777; doi:https://doi.org/10.1101/2022.01.05.22268777. Accepted in Scientific report
    227. Potdar V, Brijwal M, Lodha R, Yadav P, Jadhav S, Choudhary ML, Choudhary A, Vipat V, Gupta N, Deorari AK, Dar L, Abraham P. Identification of Human Case of Avian Influenza A(H5N1) Infection, India. Emerg Infect Dis. 2022 Jun;28(6):1269-1273. doi: 10.3201/eid2806.212246. PMID: 35608874; PMCID: PMC9155886.
    228. *Yadav PD, Mohandas S, Shete AM, Nyayanit DA, Gupta N, Patil DY, Sapkal GN, Potdar V, Kadam M, Kumar A, Kumar S, Suryavanshi D, Mote CS, Abraham P, Panda S, Bhargava B. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model. Vector Borne Zoonotic Dis. 2022 May;22(5):289-296. doi: 10.1089/vbz.2021.0080. PMID: 35580212.
    Preprints published during year 2020-22
    229. Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Dugyala R, Usha Praturi, Gajanan Sapkal, Yadav PD. et al. Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report. medRxiv 2020.12.21.20248643; DOI: https://doi.org/10.1101/2020.12.21.20248643(Preprint)
    230. Mohandas S, *Yadav PD, Shete A, et al. Immunogenicity and protective efficacy of BBV152: a whole virion inactivated SARS CoV-2 vaccine in the Syrian hamster model. Research Square 2020. DOI: https://doi.org/10.21203/rs.3.rs-76768/v1(Preprint)
    231. *Yadav PD, Ella R, Mohandas S, Shete A, Bhati G, Sapkal G, Kaushal H. et al. Remarkable immunogenicity and protective efficacy of BBV152, an inactivated SARS-CoV-2 vaccine in rhesus macaques. Research Square. DOI:10.21203/rs.3.rs-65715/v1(Preprint)
    232. Agarwal A, Mukherjee Aparna, Gunjan Kumar, Yadav PD& PLACID Trial Collaborators. Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial). medRxiv 2020.09.03.20187252; doi:https://doi.org/10.1101/2020.09.03.20187252 (Preprint)
    233. Ganneru B, Jogdand H, Dharam VK, Molugu NR, Prasad SD, Vellimudu S, Ella KM, Ravikrishnan R, Awasthi A, Jose J, Rao P, Kumar D, Raches Ella, Abraham p, Yadav PD,Sapkal GN, Shete A, Desphande GR, Mohandas S, Basu A, Gupta N, Vadrevu KM. Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152. bioRxiv 2020.09.09.285445.DOI: https://doi.org/10.1101/2020.09.09.285445(Preprint)
    234. Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Dugyala R, Usha Praturi, Gajanan Sapkal, Yadav PD, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Amit Bhate, Sanjay Rai, Samiran Panda, Priya Abraham, Nivedita Gupta, Krishna Ella, Balram Bhargava, Krishna Mohan Vadrevu. Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report. medRxiv 2020.12.21.20248643;.doi: https://doi.org/10.1101/2020.12.21.20248643(Preprint)
    235. Sapkal GN, *Yadav PD, Ella R, Deshpande G, Sahay R, Gupta N, Mohan VK, Abraham P, Panda S, Bhargava B. Neutralization of UK-variant VUI-202012/01 with COVAXIN vaccinated human serum. bioRxiv. 2021 Jan 1. DOI: https://doi.org/10.1101/2021.01.26.426986(Preprint)
    236. *Yadav PD, Kumar S, Agarwal K, Jain M, Patil D, Maithal K, Mathapati B, Giri S, Mohandas S, Shete A, Sapkal G. Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection. bioRxiv. 2021 Jan 1.DOI: https://doi.org/10.1101/2021.02.02.429480(Preprint)
    237. Mohandas S, *Yadav PD, Nyayanit D, Aich A, Sarkale P, Hundekar S, Kumar S, Lole K. Comparison of SARS-CoV-2 VOC 202012/01 (UK variant) and D614G variant transmission by different routes in Syrian hamsters. bioRxiv preprint.doi: https://doi.org/10.1101/2021.03.26.437153(Preprint)
    238. Nyayanit D, Sarkale P, Aich A, Kumar A, Patil S, Majumdar T, Baradkar S, Gawande P, Mohandas S, *Yadav PD. Possible role of accessory proteins in the viral replication for the 20I/501Y.V1 (B.1.1.7) SARS-CoV-2 variant. bioRxiv 2021.04.30.442222; doi: https://doi.org/10.1101/2021.04.30.442222(Preprint)
    239. *Yadav PD, Sarkale P, Razdan A, Gupta N, Nyayanit D, Sahay R, Potdar V, Patil D, Baradkar S, Kumar A, Aggarwal N, Shete A, Kaur H. Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travelers. bioRxiv preprint doi: https://doi.org/10.1101/2021.05.14.443968. (Preprint)
    240. Raches Ella, Siddarth Reddy, William Blackwelder, Varsha Potdar, Yadav PD, et al Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trial. medRxiv 2021.06.30.21259439; doi: https://doi.org/10.1101/2021.06.30.21259439(Preprint)
    241. *Yadav PD, Sapkal G, Abraham P, Ella R, Deshpande G, Patil D, Nyayanit D, Gupta N, Sahay R, Shete A, Panda S, Bhargava, Mohan K. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. bioRxiv preprint. doi: https://doi.org/10.1101/2021.04.23.441101. (Preprint)
    242. *Yadav PD, Sapkal G, Abraham P, Deshpande G, Nyayanit D, Patil D, Gupta N, Sahay R, Shete A, Kumar S, Panda S, Bhargava B. Neutralization potential of Covishield vaccinated individuals against B.1.617. 1. bioRxiv preprint. doi: https://doi.org/10.1101/2021.05.12.443645(Preprint).
    243. *Yadav PD, Mohandas S, Aich A, Nayanit D, Gupta N, Patil D, Sapkal G, Potdar V, Kadam M, Kumar A, Suryavanshi D, Mote C, Abraham P, Panda S, Bhargava B. SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters then B.1 variant. bioRxiv preprint 2021.05.05.442760;doi:https://doi.org/10.1101/2021.05.442760. (Preprint).
    244. *Yadav PD, Sapkal GN et al. Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152. bioRxiv; 2021. DOI: 10.1101/2021.06.05.447177 (Preprint)
    245. Sapkal G, *Yadav PD, Ella R, Abraham P, Patil D, Gupta N, Panda S, Mohan V, Bhargava B. Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of BBV152 vaccine. bioRxiv preprint doi: https://doi.org/10.1101/2021.04.30.441559. (Preprint)
    246. *Yadav PD, Sreelekshmy Mohandas, Prasad Sarkale, Dimpal Nyayanit et al. Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model. bioRxiv 2021.05.24.445424; doi: https://doi.org/10.1101/2021.05.24.445424(Preprint)
    247. Cherian S, Potdar V, Jadhav S, *Yadav PD, Gupta N, Das M, Rakshit P, Singh S, Abraham P, Panda S. Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India. bioRxiv. 2021 Jan 1. (Preprint)
    248. Sapkal GN, *Yadav PD, Rima R. Sahay, Gururaj Deshpande, Nivedita Gupta et al. Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals. bioRxiv 2021.07.01.450676; doi: https://doi.org/10.1101/2021.07.01.450676 (Preprint)
    249. *Yadav PD, Sahay RR, Sapkal G, Nyayanit D, Shete AM et al. Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152. bioRxiv 2021.07.30.454511; doi: https://doi.org/10.1101/2021.07.30.454511 (Preprint)
    250. *Yadav PD, GN Sapkal, Priya Abraham, Gururaj Deshpande, Dimpal A Nyayanit, et al. Neutralization potential of Covishield vaccinated individuals sera against .1.617.1. bioRxiv 2021.05.12.443645; doi: https://doi.org/10.1101/2021.05.12.443645(Preprint)
    251. Shrivastav RK, Dwivedi G, Zaman K, Rima R Sahay, Sapkal, Himanshu Kaushal, Dimpal Nyayanit, *Yadav PD, et al. Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime. medRxiv 2021.08.06.21261716; doi:https://doi.org/10.1101/2021.08.06.21261716 (Preprint)
    252. Mohandas Sreelekshmy, *Yadav PD, Shete Anita, Nyayanit Dimpal, Sapkal Gajanan, Lole Kavita, Gupta Nivedita. SARS-CoV-2 Delta variant pathogenesis and host response in Syrian hamsters. bioRxiv 2021.07.24.453631; doi: https://doi.org/10.1101/2021.07.24.453631(Preprint)
    253. Gupta N, Kaur H, *Yadav PD, Mukhopadhyay L, Rima R Sahay RR et al. Clinical characterization and Genomic analysis of COVID-19 breakthrough infections during second wave in different states of India. medRxiv 2021.07.13.21260273; doi:https://doi.org/10.1101/2021.07.13.21260273 (Preprint)
    254. *Yadav PD, Sanjeev Kumar Mendiratta, Sreelekshmy Mohandas, Arun K Singh, Priya Abraham, Anita Shete, Sanjay Bandyopadhyay, Sanjay Kumar, Aashini Parikh, Pankaj Kalita, Vibhuti Sharma, Hardik Pandya, Chirag G Patel, Mihir Patel, Swagat Soni, Suresh Giri, Mukul Jain. ZRC3308 monoclonal antibody cocktail shows protective efficacy in Syrian hamsters against SARS-CoV-2 infection bioRxiv 2021.09.16.460724; doi: https://doi.org/10.1101/2021.09.16.460724(Preprint)
    255. Sapkal GN, *Yadav PD, Gururaj Rao Deshpande et al. Development of equine antisera with high neutralizing activity against SARS-CoV-2. 2020; PREPRINT (Version 1) available at Research Square DOI:https://doi.org/10.21203/rs.3.rs-83582/v1 (Preprint)
    256. Bhatnagar Tarun, Chaudhri Sirshendu, Ponnaih Manickam, Yadav Pragya. et al. Effectiveness of BBV152/Covaxin and AZD1222/Covishield Vaccines Against Severe COVID-19 and B.1.617.2/Delta Variant in India, 2021: A Multi-Centric Hospital-Based Case-Control Study. Available at SSRN: https://ssrn.com/abstract=3955739https://dx.doi.org/10.2139/ssrn.3955739(Preprint)
    257. Yadav Pragya *, Sahay Rima, Anukumar B, Mohandas Sreelekshmy , Radhakrishnan Chandni, Gokhale Mangesh, et al. Nipah virus outbreak in Kerala state, India amidst of COVID-19 pandemic medRxiv 2021.12.09.21267278; doi:https://doi.org/10.1101/2021.12.09.21267278 (Preprint)
    258. Vadrevu KrishnaMohan , Ganneru Brunda , Reddy Siddharth , Jogdand Harsh , Dugyala Raju, Praturi Usha , Sapkal GajananN , Yadav Pragya , et al. Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial medRxiv 2022.01.05.22268777; doi:https://doi.org/10.1101/2022.01.05.22268777 (Preprint)
    259. Potdar Varsha, Yadav Pragya#, Lole Kavita , Cherian Sarah , Shastri Jayanti , Malhotra Bharati, et al. Detection of the omicron variant in international travelers and their family contacts in India medRxiv 2021.12.27.21268429; doi:https://doi.org/10.1101/2021.12.27.21268429 (Preprint)
    260. Yadav Pragya *, Gupta Nivedita , Potdar Varsha , Mohandas Sreelekshmy , Sahay Rima, et al.. An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens bioRxiv 2022.01.02.474750; doi: https://doi.org/10.1101/2022.01.02.474750(Preprint)
    261. Yadav Pragya *, Kumar Gunjan , Mukherjee Aparna , Nyayanit Dimpal , Shete Anita , Sahay Rima, et al. Delta Variant SARS-CoV-2 infections in pediatric cases during the second wave in India. medRxiv 2021.12.09.21266954; doi:https://doi.org/10.1101/2021.12.09.21266954 (Preprint)
    262. Mohandas Sreelekshmy , Yadav Pragya, Shete Anita , Nyayanit Dimpal , Jain Rajlaxmi , Sapkal Gajanan. Protective immunity of the primary SARS-CoV-2 infection reduces disease severity post re-infection with Delta variants in Syrian hamsters bioRxiv 2021.11.28.470293; doi: https://doi.org/10.1101/2021.11.28.470293(Preprint)
    263. Mohandas Sreelekshmy , Yadav Pragya*, Sapkal Gajanan , Shete Anita, Deshpande Gururaj, et al. Pathogenicity of SARS-CoV-2 Omicron in Syrian hamsters and its neutralization with different Variants of Concern. bioRxiv 2022.01.19.477013; doi: https://doi.org/10.1101/2022.01.19.477013(Preprint)
    264. Sahay Rima , Patil Deepak, Sapkal Gajanan, Deshpande Gururaj, Shete AnitaM , Nyayanit Dimpal , Kumar Sanjay , Dutta Shanta , Yadav Pragya*. SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient sera.bioRxiv 2021; doi: https://doi.org/10.1101/2021.11.30.470521(Preprint)
    265. Yadav PD*., Sapkal G, Sahay RR, Potdar V, Deshpande G, Patil DY, Nyayanit DA, Shete AM, Shastri J, Awate P, Malhotra B, Abraham P. Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns bioRxiv 2022.01.24.477043; doi: https://doi.org/10.1101/2022.01.24.477043(Preprint) 266. Sharma Ravi Prakash, Gautam Swati, Sharma Pratibha, Singh Ruchi, Sharma Himanshu, Parsoya Dinesh, Deba Farah, Bhomia Neha, pal Nita,Potdar Varsha, Yadav PD et al. Clinico epidemiological profile of Omicron variant of SARS CoV2 in Rajasthan medRxiv 2022.02.11.22270698; doi: https://doi.org/10.1101/2022.02.11.22270698 (Preprint)
    267. Shete AM, Patil DY, Sahay RR, Sapkal GN, Deshpande GR, Yadav PD. Low immune response after 1.5 years of primary SARS-CoV-2 infection and Covishield vaccination lead to SARS-CoV-2 reinfection. bioRxiv 2022.05.12.491584; doi: https://doi.org/10.1101/2022.05.12.491584 (Preprint)
    268. Yadav PD, Mohandas S, Shete A, Sapkal G, Deshpande G, Kumar A, Wakchaure K, Dighe H, Jain R, Ganneru B, Yemul J. Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model. bioRxiv. 2022 June 14. (Preprint)
    269. Cumulative impact factor and citations

 

All for Joomla All for Webmasters